These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10186011)

  • 1. Tapping the savings from vitamin-based prevention.
    Leader S; Mallick R
    Manag Care Interface; 1998 Oct; 11(10):95-9. PubMed ID: 10186011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential health economic benefits of vitamin supplementation.
    Bendich A; Mallick R; Leader S
    West J Med; 1997 May; 166(5):306-12. PubMed ID: 9217432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spina bifida and anencephaly before and after folic acid mandate--United States, 1995-1996 and 1999-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 May; 53(17):362-5. PubMed ID: 15129193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of infants with neural tube defects in the presence of folic acid fortification.
    Bol KA; Collins JS; Kirby RS;
    Pediatrics; 2006 Mar; 117(3):803-13. PubMed ID: 16510661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospitalizations of newborns with folate-sensitive birth defects before and after fortification of foods with folic acid.
    Robbins JM; Tilford JM; Bird TM; Cleves MA; Reading JA; Hobbs CA
    Pediatrics; 2006 Sep; 118(3):906-15. PubMed ID: 16950980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of infant methylenetetrahydrofolate reductase genotype, maternal vitamin use, and risk of high versus low level spina bifida defects.
    Volcik KA; Shaw GM; Lammer EJ; Zhu H; Finnell RH
    Birth Defects Res A Clin Mol Teratol; 2003 Mar; 67(3):154-7. PubMed ID: 12797455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How much money can early prenatal care for teen pregnancies save?: a cost-benefit analysis.
    Hueston WJ; Quattlebaum RG; Benich JJ
    J Am Board Fam Med; 2008; 21(3):184-90. PubMed ID: 18467529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The scientific basis for eliminating folic acid-preventable spina bifida: a modern miracle from epidemiology.
    Oakley GP
    Ann Epidemiol; 2009 Apr; 19(4):226-30. PubMed ID: 19344858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of a neural tube defect recurrence-prevention program.
    Grosse SD; Ouyang L; Collins JS; Green D; Dean JH; Stevenson RE
    Am J Prev Med; 2008 Dec; 35(6):572-7. PubMed ID: 18845415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preconception care: preliminary estimates of costs and effects of smoking cessation and folic acid supplementation.
    de Weerd S; Polder JJ; Cohen-Overbeek TE; Zimmermann LJ; Steegers EA
    J Reprod Med; 2004 May; 49(5):338-44. PubMed ID: 15214705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of vitamins containing folic acid among women of childbearing age--United States, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Sep; 53(36):847-50. PubMed ID: 15371968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of folic acid and other vitamins before and during pregnancy in a group of women in Melbourne, Australia.
    Forster DA; Wills G; Denning A; Bolger M
    Midwifery; 2009 Apr; 25(2):134-46. PubMed ID: 17543431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on prevention of folic acid-preventable spina bifida and anencephaly.
    Bell KN; Oakley GP
    Birth Defects Res A Clin Mol Teratol; 2009 Jan; 85(1):102-7. PubMed ID: 19067404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neural tube defects and folic acid].
    Ritvanen A
    Duodecim; 1996; 112(11):975-82. PubMed ID: 10592990
    [No Abstract]   [Full Text] [Related]  

  • 15. For every dollar spent--the cost-savings argument for prenatal care.
    Huntington J; Connell FA
    N Engl J Med; 1994 Nov; 331(19):1303-7. PubMed ID: 7935689
    [No Abstract]   [Full Text] [Related]  

  • 16. Retrospective Assessment of Cost Savings From Prevention: Folic Acid Fortification and Spina Bifida in the U.S.
    Grosse SD; Berry RJ; Mick Tilford J; Kucik JE; Waitzman NJ
    Am J Prev Med; 2016 May; 50(5 Suppl 1):S74-S80. PubMed ID: 26790341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When will we eliminate folic acid-preventable spina bifida?
    Oakley GP
    Epidemiology; 2007 May; 18(3):367-8. PubMed ID: 17435446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Folic acid use by pregnant women in Israel for preventing neural tube defects].
    Gil Z; Aran A; Friedman O; Beni-Adani L; Constantini S
    Harefuah; 2000 Dec; 139(11-12):416-20, 495. PubMed ID: 11341184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of a folic acid fortification program in Chile.
    Llanos A; Hertrampf E; Cortes F; Pardo A; Grosse SD; Uauy R
    Health Policy; 2007 Oct; 83(2-3):295-303. PubMed ID: 17363103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre-eclampsia in populations of low nutritional status from developing countries.
    Villar J; Purwar M; Merialdi M; Zavaleta N; Thi Nhu Ngoc N; Anthony J; De Greeff A; Poston L; Shennan A;
    BJOG; 2009 May; 116(6):780-8. PubMed ID: 19432566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.